|
JPH0812695A
(ja)
*
|
1994-06-30 |
1996-01-16 |
Nisshin Oil Mills Ltd:The |
新規シアル酸供与体
|
|
US7569376B2
(en)
|
2002-05-03 |
2009-08-04 |
Neose Technologies, Inc. |
Fucosyltransferase fusion protein
|
|
CA2441677A1
(en)
|
2003-05-09 |
2004-11-09 |
Adaltis Inc. |
Peptides and mixtures thereof for detecting antibodies to severe acute respiratory syndrome-associated coronavirus
|
|
US20090214590A1
(en)
|
2005-07-08 |
2009-08-27 |
Wayne State University |
Virus Vaccines Comprising Envelope-Bound Immunomodulatory Proteins and Methods of Use Thereof
|
|
US7871626B2
(en)
|
2005-08-04 |
2011-01-18 |
St. Jude Children's Research Hospital |
Modified influenza virus for monitoring and improving vaccine efficiency
|
|
DK3438131T3
(da)
|
2006-02-10 |
2022-04-11 |
Life Technologies Corp |
Oligosaccharidmodifikation og mærkning af proteiner
|
|
PT2170365T
(pt)
|
2007-06-25 |
2016-07-12 |
Autoimmune Tech Llc |
Composições e métodos inibidores de influenza
|
|
EP2014681A1
(en)
|
2007-07-12 |
2009-01-14 |
Pierre Fabre Medicament |
Novel antibodies inhibiting c-met dimerization, and uses thereof
|
|
US7981428B2
(en)
|
2008-01-23 |
2011-07-19 |
Academia Sinica |
Flu vaccines and methods of use thereof
|
|
RU2011111640A
(ru)
|
2008-08-29 |
2012-10-10 |
Симфоген А/С (Dk) |
Антитела против cd5
|
|
CN107375919B
(zh)
|
2009-03-27 |
2022-07-29 |
台湾地区“中央研究院” |
抗病毒免疫的方法和组合物
|
|
HUE039100T2
(hu)
|
2009-06-24 |
2018-12-28 |
Medicago Inc |
Hemagglutinint tartalmazó kimer influenzavírus-jellegû részecskék
|
|
US20130005797A1
(en)
|
2010-03-18 |
2013-01-03 |
Merck Sharp & Dohme Corp. |
Endosomolytic poly(amidoamine) disulfide polymers for the delivery of oligonucleotides
|
|
AR083533A1
(es)
|
2010-10-22 |
2013-03-06 |
Boehringer Ingelheim Vetmed |
Proteinas de hemaglutinina 5 (h5) para el tratamiento y prevencion de las infecciones de gripe
|
|
FR2968999B1
(fr)
|
2010-12-20 |
2013-01-04 |
Guerbet Sa |
Nanoemulsion de chelate pour irm
|
|
EP2654787A1
(en)
|
2010-12-22 |
2013-10-30 |
Novavax, Inc. |
Modified influenza hemagglutinin proteins and uses thereof
|
|
EP4241785B1
(en)
|
2011-09-20 |
2026-01-28 |
Icahn School of Medicine at Mount Sinai |
Influenza virus vaccines and uses thereof
|
|
WO2013067652A1
(en)
|
2011-11-10 |
2013-05-16 |
Beijing Advaccine Biotechnology Co., Ltd. |
Facilitator-dna combination vaccine
|
|
WO2014055474A1
(en)
|
2012-10-04 |
2014-04-10 |
Vertex Pharmaceuticals Incorporated |
Mannose derivatives for treating bacterial infections
|
|
TW201442721A
(zh)
*
|
2013-01-23 |
2014-11-16 |
Daiichi Sankyo Co Ltd |
糖鏈修飾心房利尿鈉肽
|
|
ES2802274T3
(es)
|
2013-05-02 |
2021-01-18 |
Momenta Pharmaceuticals Inc |
Glicoproteínas sialiladas
|
|
WO2015031166A1
(en)
|
2013-08-26 |
2015-03-05 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for directed immunogen evolution and uses thereof
|
|
US9975925B2
(en)
|
2013-08-28 |
2018-05-22 |
Glaxosmithkline Biologicals S.A. |
Influenza antigens and antibodies
|
|
US10421802B2
(en)
|
2013-10-18 |
2019-09-24 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Human monoclonal antibodies against the middle east respiratory syndrome coronavirus (MERS-CoV) and engineered bispecific fusions with inhibitory peptides
|
|
EP3068891A1
(en)
|
2013-11-13 |
2016-09-21 |
Aequus Biopharma Inc. |
Engineered glycoproteins and uses thereof
|
|
CN105934441A
(zh)
|
2013-11-26 |
2016-09-07 |
贝勒医学院 |
新型sars免疫原性组合物
|
|
WO2015142671A2
(en)
|
2014-03-17 |
2015-09-24 |
Flugen, Inc. |
Influenza virus vectors and uses therefor
|
|
CN104189897A
(zh)
|
2014-05-21 |
2014-12-10 |
深圳先进技术研究院 |
一种树突状细胞高效负载抗原的制备方法
|
|
CA2950415A1
(en)
|
2014-05-27 |
2015-12-03 |
Academia Sinica |
Anti-cd20 glycoantibodies and uses thereof
|
|
JP6779887B2
(ja)
|
2015-01-24 |
2020-11-04 |
アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ |
新規なグリカンコンジュゲートおよびその使用方法
|
|
WO2016138160A1
(en)
|
2015-02-24 |
2016-09-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use
|
|
WO2017062496A2
(en)
|
2015-10-05 |
2017-04-13 |
University Of Virginia Patent Foundation |
Anti-sas1b antibodies, associated methods of use, and compositions and methods for detecting and treating cancer
|
|
EP3374504B1
(en)
|
2015-11-09 |
2025-03-19 |
CureVac SE |
Optimized nucleic acid molecules
|
|
WO2018035387A1
(en)
|
2016-08-17 |
2018-02-22 |
The Broad Institute, Inc. |
Novel crispr enzymes and systems
|
|
KR101873527B1
(ko)
*
|
2016-09-02 |
2018-07-02 |
부산대학교 산학협력단 |
시알산 유도체를 포함하는 자궁내막증 예방 또는 치료용 조성물
|
|
US20180128545A1
(en)
|
2016-11-08 |
2018-05-10 |
Berry Metal Company |
Modular furnace cooling wall
|
|
CA3056206A1
(en)
|
2017-03-15 |
2018-09-20 |
Polyneuron Pharmaceuticals Ag |
Glycopolymers sequestering carbohydrate-binding proteins
|
|
US20200231633A1
(en)
|
2017-07-19 |
2020-07-23 |
The Regents Of The University Of California |
MGAT1-Deficient Cells for Production of Vaccines and Biopharmaceutical Products
|
|
AU2018312563A1
(en)
|
2017-08-01 |
2020-03-12 |
City Of Hope |
Anti-IL1RAP antibodies
|
|
CN111770991A
(zh)
|
2017-12-18 |
2020-10-13 |
通用医疗公司 |
糖工程
|
|
US11191777B2
(en)
|
2018-06-20 |
2021-12-07 |
International Business Machines Corporation |
Antimicrobial guanidinium macromolecules with bacteria targeting moieties
|
|
CA3104297A1
(en)
|
2018-06-21 |
2019-12-26 |
Icahn School Of Medicine At Mount Sinai |
Mosaic influenza virus hemagglutinin polypeptides and uses thereof
|
|
CN110713537B
(zh)
|
2018-07-13 |
2023-04-21 |
江苏怀瑜药业有限公司 |
一种sema4d抗体及其制备方法和应用
|
|
KR20210061393A
(ko)
|
2018-09-18 |
2021-05-27 |
유니버시테이트 젠트 |
치료용 나노입자 및 이의 사용 방법
|
|
WO2020077159A1
(en)
|
2018-10-10 |
2020-04-16 |
The Johns Hopkins University |
POLY(Beta-AMINO ESTER) NANOPARTICLES FOR THE NON-VIRAL DELIVERY OF PLASMID DNA FOR GENE EDITING AND RETINAL GENE THERAPY
|
|
WO2020172072A1
(en)
|
2019-02-21 |
2020-08-27 |
The General Hospital Corporation |
Glycoengineering immunoglobulin e
|
|
WO2020198865A1
(en)
|
2019-04-03 |
2020-10-08 |
The University Of British Columbia |
Oligopeptides for quantitative viral proteomic analysis methods and uses
|
|
US12384811B2
(en)
|
2019-04-05 |
2025-08-12 |
Academia Sinica |
Sialidase-resistant saccharide and method of making and using the same
|
|
GB201908352D0
(en)
|
2019-06-11 |
2019-07-24 |
Innovation Ulster Ltd |
Sonodynamic therapy
|
|
FR3098110B1
(fr)
|
2019-07-03 |
2022-02-04 |
Chanel Parfums Beaute |
Composition cosmétique solide
|
|
BR112022001185A2
(pt)
|
2019-08-01 |
2022-03-15 |
Acm Biolabs Pte Ltd |
Método de eliciamento de uma resposta imune administrando uma população de polimerossomos tendo um antígeno associado com uma população de polimerossomos tendo um adjuvante associado, bem como composições compreendendo as duas populações de polimerossomos
|
|
BR102019017792A2
(pt)
|
2019-08-27 |
2021-11-16 |
Fundação Oswaldo Cruz |
Receptáculo proteico, método para produção do receptáculo, método de identificação de patógenos ou de diagnóstico de doenças, e, uso do receptáculo
|
|
US20220387461A1
(en)
|
2019-09-04 |
2022-12-08 |
Victoria Link Ltd |
Cancer vaccine
|
|
US10953089B1
(en)
|
2020-01-27 |
2021-03-23 |
Novavax, Inc. |
Coronavirus vaccine formulations
|
|
WO2021174128A1
(en)
|
2020-02-26 |
2021-09-02 |
University Of Maryland, College Park |
Compositions and methods for mucosal vaccination against sars-cov-2
|
|
MX2022011142A
(es)
|
2020-03-09 |
2022-12-13 |
Abcellera Biologics Inc |
Anticuerpos anti-coronavirus y metodos de uso.
|
|
GB202003632D0
(en)
|
2020-03-12 |
2020-04-29 |
Harbour Antibodies Bv |
SARS-Cov-2 (SARS2, COVID-19) antibodies
|
|
IL296426A
(en)
|
2020-03-19 |
2022-11-01 |
Baseclick Gmbh |
Maran"im that underwent a change for the development of a component
|
|
KR20250107297A
(ko)
|
2020-04-02 |
2025-07-11 |
리제너론 파아마슈티컬스, 인크. |
항-sars-cov-2 스파이크 당단백질 항체 및 항원-결합 단편
|
|
US20210316002A1
(en)
|
2020-04-14 |
2021-10-14 |
Ut-Battelle, Llc |
Compositions and methods for drug delivery and treating viral infections
|
|
IL297419B2
(en)
|
2020-04-22 |
2025-02-01 |
BioNTech SE |
Coronavirus vaccine
|
|
RU2720614C9
(ru)
|
2020-04-23 |
2021-02-09 |
федеральное государственное бюджетное учреждение «Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи» Министерства здравоохранения Российской Федерации |
Иммунобиологическое средство и способ его использования для индукции специфического иммунитета против вируса тяжелого острого респираторного синдрома SARS-CoV-2 (варианты)
|
|
KR20230005962A
(ko)
|
2020-05-01 |
2023-01-10 |
니코데 테라퓨틱스 에이에스에이 |
베타코로나바이러스 예방 및 치료요법
|
|
TWI870591B
(zh)
|
2020-05-08 |
2025-01-21 |
中央研究院 |
嵌合流感疫苗
|
|
IL298333A
(en)
|
2020-05-20 |
2023-01-01 |
Alexandru Adrian Hennrich |
A viral assembly vector for a vaccine against the corona virus cell
|
|
CN116322732A
(zh)
|
2020-06-17 |
2023-06-23 |
迪斯拉普申实验室公司 |
用治疗剂补充产品的组合物及其使用方法
|
|
US10906944B2
(en)
|
2020-06-29 |
2021-02-02 |
The Scripps Research Institute |
Stabilized coronavirus spike (S) protein immunogens and related vaccines
|
|
RU2730897C1
(ru)
|
2020-07-01 |
2020-08-26 |
Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) |
СПОСОБ ИСПОЛЬЗОВАНИЯ РЕКОМБИНАНТНЫХ БЕЛКОВ SARS-COV-2 В СОСТАВЕ ТЕСТ-СИСТЕМЫ ДЛЯ ИММУНОФЕРМЕНТНОГО АНАЛИЗА С ОПРЕДЕЛЕНИЕМ УРОВНЕЙ АНТИТЕЛ КЛАССОВ IgM, IgG, IgA В СЫВОРОТКЕ/ПЛАЗМЕ КРОВИ БОЛЬНЫХ COVID-19
|
|
WO2022047401A1
(en)
|
2020-08-31 |
2022-03-03 |
The University Of Chicago |
Targeted, intracellular delivery of therapeutic peptides using supramolecular nanomaterials
|
|
CN112626124B
(zh)
|
2020-10-15 |
2023-04-11 |
广州达博生物制品有限公司 |
一种病毒保存试剂
|
|
BR112023005961A2
(pt)
|
2021-04-12 |
2023-10-24 |
Academia Sinica |
Molécula de ácido nucleico modificada, vacina combinada, nanopartícula, nanocluster de mrna, método para prevenir ou tratar uma infecção por coronavírus, método para reforço de uma resposta imune adaptativa, peptídeo imunogênico e composição imunogênica
|
|
BR112023000666A2
(pt)
|
2021-04-12 |
2023-10-24 |
Academia Sinica |
Imunógeno, composição imunogênica, método para induzir uma resposta imune contra um coronavírus 2 da síndrome respiratória aguda grave e uso da composição imunogênica
|
|
JP2024517711A
(ja)
|
2021-04-29 |
2024-04-23 |
ノバルティス アーゲー |
高シアル酸付加細胞
|
|
CN113265050B
(zh)
|
2021-04-30 |
2022-08-23 |
浙江大学 |
一种可降解高分子材料和自组装纳米复合物及应用
|
|
GB202111759D0
(en)
|
2021-08-17 |
2021-09-29 |
Cantab Biopharmaceuticals Patents Ltd |
Modified colloidal particles
|
|
TW202334429A
(zh)
|
2021-10-01 |
2023-09-01 |
中央研究院 |
Sars-cov-2棘蛋白特異性抗體及其用途
|
|
US20250195639A1
(en)
|
2021-10-20 |
2025-06-19 |
The Regents Of The University Of California |
Multi-epitope mrna sars-cov-2 vaccine for boosting immunity through the activation of cd4 and cd8 t cells as well as b lymphocytes
|
|
WO2023129928A2
(en)
|
2021-12-27 |
2023-07-06 |
Academia Sinica |
Antibody specific to spike protein of sars-cov-2 and uses thereof
|
|
CN116478948A
(zh)
|
2023-03-01 |
2023-07-25 |
中山大学 |
一种生成高唾液酸化蛋白药物的细胞工程方法
|
|
AU2024252371B2
(en)
|
2023-04-08 |
2026-02-12 |
Rock Biomedical Inc. |
Methods and compositions for dendritic cell targeting nano-delivery
|
|
WO2024215616A2
(en)
|
2023-04-08 |
2024-10-17 |
Rock Biomedical Inc. |
Methods and compositions for dendritic cell targeting vaccines
|
|
US12318485B2
(en)
|
2023-04-08 |
2025-06-03 |
Rock Biomedical, Inc. |
Methods and compositions for targeted delivery by polymersomes
|
|
WO2024238734A2
(en)
|
2023-05-17 |
2024-11-21 |
Rock Biomedical Inc. |
Mgat1 deficient cells and uses thereof
|